-
2
-
-
2442526224
-
Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: A metaanalysis of blinded, randomized, placebo-controlled trials
-
Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkan B & Chanson P. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. Journal of Clinical Endocrinology and Metabolism 2004 89 2192-2199.
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, pp. 2192-2199
-
-
Maison, P.1
Griffin, S.2
Nicoue-Beglah, M.3
Haddad, N.4
Balkan, B.5
Chanson, P.6
-
3
-
-
0034749231
-
A prospective study of 5 years of GH replacement therapy in GH-deficient adults: Sustained effects on body composition, bone mass, and metabolic indices
-
Gotherstrom G, Svensson J, Koranyi J, Alpsten M, Bosaeus I, Bengtsson B & Johannsson G. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. Journal of Clinical Endocrinology and Metabolism 2001 86 4657-4665.
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, pp. 4657-4665
-
-
Gotherstrom, G.1
Svensson, J.2
Koranyi, J.3
Alpsten, M.4
Bosaeus, I.5
Bengtsson, B.6
Johannsson, G.7
-
4
-
-
0033756446
-
Effects of 7 years of growth hormone replacement therapy in hypopituitary adults
-
Chrisoulidou A, Beshyah SA, Rutherford O, Spinks TJ, Mayet J, Kyd P, Anyaoku V, Haida A, Ariff B, Murphy M, Thomas E, Robinson S, Foale R & Johnston DG. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism 2000 85 3762-3769.
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, pp. 3762-3769
-
-
Chrisoulidou, A.1
Beshyah, S.A.2
Rutherford, O.3
Spinks, T.J.4
Mayet, J.5
Kyd, P.6
Anyaoku, V.7
Haida, A.8
Ariff, B.9
Murphy, M.10
Thomas, E.11
Robinson, S.12
Foale, R.13
Johnston, D.G.14
-
5
-
-
0033345441
-
The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients
-
Gibney J, Wallace JD, Spinks T, Schnorr L, Ranicar A, Cuneo RC, Lockhart S, Burnand KG, Salomon F, Sonksen PH & Russell-Jones D. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 1999 84 2596-2602.
-
(1999)
Journal of Clinical Endocrinology and Metabolism
, vol.84
, pp. 2596-2602
-
-
Gibney, J.1
Wallace, J.D.2
Spinks, T.3
Schnorr, L.4
Ranicar, A.5
Cuneo, R.C.6
Lockhart, S.7
Burnand, K.G.8
Salomon, F.9
Sonksen, P.H.10
Russell-Jones, D.11
-
6
-
-
0037693145
-
Five years of growth hormone replacement therapy in adults: Age- and gender-related changes in isometric and isokinetic muscle strength
-
Svensson J, Stibrant SK & Johannson G. Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength. Journal of Clinical Endocrinology and Metabolism 2003 88 2061-2069.
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, pp. 2061-2069
-
-
Svensson, J.1
Stibrant, S.K.2
Johannson, G.3
-
7
-
-
0036096692
-
Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults
-
Svensson J, Fowelin J, Landin K, Bengtsson BA & Johansson JO. Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 2002 87 2121-2127.
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, pp. 2121-2127
-
-
Svensson, J.1
Fowelin, J.2
Landin, K.3
Bengtsson, B.A.4
Johansson, J.O.5
-
8
-
-
0031863120
-
Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults
-
Al-Shoumer KA, Gray R, Anyaoku V, Hughes C, Beshyah S, Richmond W & Johnston DG. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical Endocrinology 1998 48 795-802.
-
(1998)
Clinical Endocrinology
, vol.48
, pp. 795-802
-
-
Al-Shoumer, K.A.1
Gray, R.2
Anyaoku, V.3
Hughes, C.4
Beshyah, S.5
Richmond, W.6
Johnston, D.G.7
-
9
-
-
0030740995
-
Growth hormone-induced insulin resistance: Role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4
-
Smith TR, Elmendorf JS, David TS & Turinsky J. Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. American Journal of Physiology 1997 272 E1071-E1079.
-
(1997)
American Journal of Physiology
, vol.272
-
-
Smith, T.R.1
Elmendorf, J.S.2
David, T.S.3
Turinsky, J.4
-
11
-
-
23744434990
-
Dysglycemia, not just diabetes, is a continuous risk factor for cardiovascular disease
-
Gerstein HC. Dysglycemia, not just diabetes, is a continuous risk factor for cardiovascular disease. Evidence-Based Cardiovascular Medicine 1997 1 87-88.
-
(1997)
Evidence-Based Cardiovascular Medicine
, vol.1
, pp. 87-88
-
-
Gerstein, H.C.1
-
12
-
-
0032902850
-
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years
-
Coutinho M, Gerstein HC, Wang Y & Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999 22 233-240.
-
(1999)
Diabetes Care
, vol.22
, pp. 233-240
-
-
Coutinho, M.1
Gerstein, H.C.2
Wang, Y.3
Yusuf, S.4
-
13
-
-
0032539940
-
Cholesterol reduction yields clinical benefit: Impact of statin trials
-
Gould AL, Rossouw JE, Santanello NC, Heyse JF & Furberg CD. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 1998 97 946-952.
-
(1998)
Circulation
, vol.97
, pp. 946-952
-
-
Gould, A.L.1
Rossouw, J.E.2
Santanello, N.C.3
Heyse, J.F.4
Furberg, C.D.5
-
14
-
-
0035897696
-
Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)
-
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)
-
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001 285 2486-2497.
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
15
-
-
0025333249
-
Premature mortality due to cardiovascular disease in hypopituitarism
-
Rosen T & Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990 336 285-288.
-
(1990)
Lancet
, vol.336
, pp. 285-288
-
-
Rosen, T.1
Bengtsson, B.A.2
-
16
-
-
0035835469
-
Association between premature mortality and hypopituitarism
-
West Midlands Prospective Hypopituitary Study Group
-
Tomlinson JW. Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC & Stewart PM. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001 357 425-431.
-
(2001)
Lancet
, vol.357
, pp. 425-431
-
-
Tomlinson, J.W.1
Holden, N.2
Hills, R.K.3
Wheatley, K.4
Clayton, R.N.5
Bates, A.S.6
Sheppard, M.C.7
Stewart, P.M.8
-
17
-
-
33646402056
-
Evaluation and treatment of adult growth hormone deficiency: An endocrine society clinical practice guideline
-
Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM & Vance ML. Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2006 91 1621-1634.
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, pp. 1621-1634
-
-
Molitch, M.E.1
Clemmons, D.R.2
Malozowski, S.3
Merriam, G.R.4
Shalet, S.M.5
Vance, M.L.6
|